Value Bridge — CHRISTUS MOTHER FRANCES HOSP-TYLER
Current $-165M → Target $-144M (+$21.5M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-165.1M
Current EBITDA
$-143.6M
Target EBITDA
+$21.5M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$4.9M
Payer Mix Optimization
$11.7M
Cost to Collect Reduction
$3.9M
Clean Claim Improvement
$2.9M
Volume & Rate Growth
$19.4M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-165M to $-144M. The highest-impact lever is Volume & Rate Growth at $7.8M probability-weighted.
IC talking point: "We see $21M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $236M in equity value creation."